MARCY BRUBACHER: Open Payments
NPI 1942533922 · HESSTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 11 companies in 2025. Trend: 2023 $299 · 2024 $230 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $68 |
| Lilly USA, LLC | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Lundbeck LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: INTELLIS ADAPTIVESTIM, MOUNJARO, REXULTI, BREZTRI, PREVNAR 20, VRAYLAR, GVOKE HYPOPEN, AJOVY.
Industry payments across KS — which companies pay providers there.
